Literature DB >> 10440438

Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine.

C R Vitek1, M Aduddell, M J Brinton, R E Hoffman, S C Redd.   

Abstract

BACKGROUND: In 1989 a second dose of measles vaccine was recommended for US children to prevent school outbreaks of measles. Coverage of school age children with a second dose remains incomplete, and data on the effectiveness of this recommendation are limited. We investigated a measles outbreak in Mesa County, CO, in December, 1994, and evaluated the efficacy of preoutbreak immunizations at an elementary school (School A) where many students had received two doses.
METHODS: All reported suspected cases of measles were investigated; cases that met a clinical case definition were tested by a measles IgM antibody assay. A confirmed case required laboratory confirmation or had to meet the clinical case definition and be epidemiologically linked to a confirmed case. Vaccination records of students at School A were reviewed. The effectiveness of one and two doses of measles vaccine was estimated using logistic regression.
RESULTS: Sixty-two confirmed cases were reported, including 17 at School A. At School A the attack rate in unvaccinated children (7 of 16, 44%) was higher than in those with 1 dose (10 of 320, 3%) or 2 doses (0 of 289, 0%). Estimated vaccine effectiveness was 92% for 1 dose and 100% for 2 doses. Two doses were better than one dose in decreasing the likelihood of acquiring measles (P = 0.003).
CONCLUSIONS: The lower attack rate among two dose recipients provides evidence that a two dose strategy can help prevent measles in schools. Administering the second dose at elementary school entry can help prevent the persistence of susceptible cohorts of children and is likely to be important in sustaining elimination of indigenous transmission of measles in the United States.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440438     DOI: 10.1097/00006454-199907000-00010

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  The Reemergence of Measles.

Authors:  C L Abad; N Safdar
Journal:  Curr Infect Dis Rep       Date:  2015-12       Impact factor: 3.725

2.  Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants.

Authors:  Beth Holder; David J C Miles; Steve Kaye; Sarah Crozier; Nuredin Ibrahim Mohammed; Nancy O Duah; Elishia Roberts; Olubukola Ojuola; Melba S Palmero; Ebrima S Touray; Pauline Waight; Matthew Cotten; Sarah Rowland-Jones; Marianne van der Sande; Hilton Whittle
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

3.  Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.

Authors:  Amy Parker Fiebelkorn; Laura A Coleman; Edward A Belongia; Sandra K Freeman; Daphne York; Daoling Bi; Ashwin Kulkarni; Susette Audet; Sara Mercader; Marcia McGrew; Carole J Hickman; William J Bellini; Rupak Shivakoti; Diane E Griffin; Judith Beeler
Journal:  J Infect Dis       Date:  2015-11-23       Impact factor: 5.226

4.  Measles outbreak in a Periurban area of Chandigarh: need for improving vaccine coverage and strengthening surveillance.

Authors:  J S Thakur; R K Ratho; S P S Bhatia; Raminder Grover; M Issaivanan; Bashir Ahmed; Veena Parmar; H M Swami
Journal:  Indian J Pediatr       Date:  2002-01       Impact factor: 5.319

5.  Stochastic modeling of empirical time series of childhood infectious diseases data before and after mass vaccination.

Authors:  Helen Trottier; Pierre Philippe; Roch Roy
Journal:  Emerg Themes Epidemiol       Date:  2006-08-08

Review 6.  New and emerging infectious diseases.

Authors:  Dirk M Elston
Journal:  J Am Acad Dermatol       Date:  2005-06       Impact factor: 11.527

7.  Cytomegalovirus infection induces T-cell differentiation without impairing antigen-specific responses in Gambian infants.

Authors:  David J C Miles; Mariama Sanneh; Beth Holder; Sarah Crozier; Samuel Nyamweya; Ebrima S Touray; Melba S Palmero; Syed M A Zaman; Sarah Rowland-Jones; Marianne van der Sande; Hilton Whittle
Journal:  Immunology       Date:  2008-01-11       Impact factor: 7.397

8.  Triangulation of measles vaccination data in the United Kingdom of Great Britain and Northern Ireland.

Authors:  Michael Edelstein; Joanne White; Antoaneta Bukasa; Vanessa Saliba; Mary Ramsay
Journal:  Bull World Health Organ       Date:  2019-08-23       Impact factor: 9.408

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.